Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Outcome Definition Influences the Relationship between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer Patients

10 May 2019

Abstract excerpt

Although previous research identified candidate genetic polymorphisms associated with cisplatin nephrotoxicity, varying outcome definitions potentially contributed to the variability in the effect size and direction of this relationship. We selected genetic variants that have been significantly associated with cisplatin-induced nephrotoxicity in more than one published study (SLC22A2 rs316019; ERCC1 rs11615 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemotherapy-induced organ toxicity mitigation

Share to Testicular diseases and treatments

Source

Identifiers

PMID: 31083486
DOI: 10.3390/genes10050364

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Outcome Definition Influences the Relationship between Genetic Polymorphisms of ERCC1, ERCC2, SLC22A2 and Cisplatin Nephrotoxicity in Adult Testicular Cancer PatientsPMID 31083486Read ↗

Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving CisplatinSemantic proximity Read ↗

Prediction of Nephrotoxicity Associated With Cisplatin-Based Chemotherapy in Testicular Cancer PatientsSemantic proximity Read ↗

Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events.Semantic proximity Read ↗

Genome-Wide Analyses of Nephrotoxicity in Platinum-Treated Cancer Patients Identify Association with Genetic Variant in RBMS3 and Acute Kidney InjurySemantic proximity Read ↗

Pharmacogenetic analyses of cisplatin-induced nephrotoxicity indicate a renoprotective effect of ERCC1 polymorphisms.Semantic proximity Read ↗

Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity.Semantic proximity Read ↗

Phenotype standardization for drug-induced kidney disease.Semantic proximity Read ↗

Multiple analytical approaches demonstrate a complex relationship of genetic and nongenetic factors with cisplatin- and carboplatin-induced nephrotoxicity in lung cancer patients.Semantic proximity Read ↗

MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer.Semantic proximity Read ↗

Absence of effect of SLC22A2 genotype on cisplatin-induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5-fluorouracil: report of results discordant with those of earlier studies.Semantic proximity Read ↗

Influence of Genetic Variation in COMT on Cisplatin-Induced Nephrotoxicity in Cancer Patients.Semantic proximity Read ↗

Epigenetic Regulation in Kidney Toxicity: Insights From Cisplatin NephrotoxicitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.